In the Media

Researchers have developed a microfluidic platform called “physiome on a chip”, which allows them to determine how certain drugs will affect up to 10 different organs. “Because the animal and human immune systems are different, [drug] testing is difficult in non-human trials,” writes Allen Cone for UPI, “but [this] system could help with that.”